Hyptis eriocephala para Tos y afecciones respiratorias
Hyptis eriocephala — 5 estudios científicos revisados
Moderate¿Sirve Hyptis eriocephala para tos y afecciones respiratorias?
Uso documentado en la medicina tradicional y respaldado por investigación preliminar
Compuestos activos involucrados: Terpenos, Cariofileno, Fenoles, Aceite esencial, Polifenoles, Quercetina, Saponinas, Alcaloides
Evidencia Científica
Los siguientes estudios han investigado la relación entre Hyptis eriocephala y tos y afecciones respiratorias:
Subtribe Hyptidinae (Lamiaceae): A promising source of bioactive metabolites.
ETHNOPHARMACOLOGICAL RELEVANCE: The subtribe Hyptidinae contains approximately 400 accepted species distributed in 19 genera (Hyptis, Eriope, Condea, Cantinoa, Mesosphaerum, Cyanocephalus, Hypenia, Hyptidendron, Oocephalus, Medusantha, Gymneia, Marsypianthes, Leptohyptis, Martianthus, Asterohyptis, Eplingiella, Physominthe, Eriopidion and Rhaphiodon). This is the Lamiaceae clade with the largest number of species in Brazil and high rates of endemism. Some species have been used in different parts of the world mainly as insecticides/pest repellents, wound healing and pain-relief agents, as well
PubMed: 32763419Oxidative Stress in Spinocerebellar Ataxia Type 3 and Its Attenuation by Herbal Remedies in Traditional Chinese Medicine: A Systematic Review.
Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disorder that gives rise to motor incoordination and progressive functional disabilities. Although pharmacological interventions have revealed promising prospects in the management of SCA3, adverse effects may become unbearable. The use of herbal remedies in traditional Chinese medicine (TCM) may serve as potential alternative medicines to delay the progression of the disease. This systematic review is intended to identify, appraise, and summarize the findings of studies pertaining to the therapeutic roles of herba
PubMed: 38539908Hyptis verticillata Jacq: a review of its traditional uses, phytochemistry, pharmacology and toxicology.
ETHNOPHARMACOLOGICAL RELEVANCE: Hyptis verticillata Jacq. (Lamiaceae) (John Charles) is an important medicinal plant with a long history of traditional use, originating in Central America and now extending from Florida to Colombia and across the Caribbean. Records of its earliest use date back to the ancient Mayan and Aztec cultures of Mesoamerica. There is no indication that this plant is being used outside of the Americas. AIM OF THE REVIEW: This review aims to provide a comprehensive overview of the traditional use, phytochemistry, pharmacological activity and toxicology of Hyptis verticill
PubMed: 23403358The essential oils chemical compositions and antimicrobial, antioxidant activities and toxicity of three Hyptis species.
CONTEXT: Hyptis suaveolens (Linn.) Poit., Hyptis rhomboidea Mart. et Gal., and Hyptis brevipes Poit., are three species of Hyptis Jacq. (Lamiaceae). Hyptis suaveolens is used for the treatment of fever, headache, gastrointestinal bloating and rheumatism in the traditional folk medicine; Hyptis rhomboidea for hepatitis, ulcer and swollen poison; and Hyptis brevipes for asthma and malaria. OBJECTIVE: To characterize chemical compositions of the oils from three Hyptis species and evaluate their potential antimicrobial, radical scavenging activities and toxicities against brine shrimp.
PubMed: 23763698Aryltetralin lignans from Hyptis brachiata inhibiting T lymphocyte proliferation.
Increased activation and proliferation of T lymphocytes plays an essential role in the development of chronic inflammation and autoimmune diseases. Currently used immunosuppressive drugs often do not provide long-lasting relief of symptoms and show a gradual loss of efficacy over time, and are accompanied by various side effects. Therefore, novel immunosuppressive lead substances are needed. For this purpose, an in-house library consisting of 600 extracts of plants from Panama was screened for inhibition of human T lymphocyte proliferation. As one of the hits, an ethyl acetate extract from the
PubMed: 36739759Seguridad y Precauciones
La seguridad en el uso de Hyptis eriocephala es un área que requiere precaución extrema debido a la falta de estudios clínicos robustos en humanos. En el caso de mujeres embarazadas o en periodo de lactancia, el uso de esta planta está estrictamente desaconsejado. No existen datos que garanticen la ausencia de efectos teratogénicos (malformaciones fetales) o la seguridad de los metabolitos secundarios durante el desarrollo embrionario. Dado que compuestos de la subtribu Hyptidinae pueden contener lignanos como la podofilotoxina, existe un riesgo potencial de toxicidad celular que podría interferir con la división celular normal del feto. En la lactancia, no se puede determinar si los compuestos bioactivos se excretan en la leche materna ni su impacto en el desarrollo del lactante. Para niños menores de 12 años, la seguridad es desconocida; sus sistemas metabólicos y órganos en desarrollo son mucho más sensibles a las variaciones farmacológicas, y la falta de dosis estandarizadas aumenta el riesgo de toxicidad aguda o crónica.
Otras plantas estudiadas para Tos y afecciones respiratorias
Perfil completo: Ver todos los usos y evidencia de Hyptis eriocephala →